Unknown

Dataset Information

0

Second Generation Amphiphilic Poly-Lysine Dendrons Inhibit Glioblastoma Cell Proliferation without Toxicity for Neurons or Astrocytes.


ABSTRACT: Glioblastomas are the most common malignant primary brain tumours in adults and one of the most aggressive and difficult-to-treat cancers. No effective treatment exits actually for this tumour and new therapeutic approaches are needed for this disease. One possible innovative approach involves the nanoparticle-mediated specific delivery of drugs and/or genetic material to glioblastoma cells where they can provide therapeutic benefits. In the present work, we have synthesised and characterised several second generation amphiphilic polylysine dendrons to be used as siRNA carriers. We have found that, in addition to their siRNA binding properties, these new compounds inhibit the proliferation of two glioblastoma cell lines while being nontoxic for non-tumoural central nervous system cells like neurons and glia, cell types that share the anatomical space with glioblastoma cells during the course of the disease. The selective toxicity of these nanoparticles to glioblastoma cells, as compared to neurons and glial cells, involves mitochondrial depolarisation and reactive oxygen species production. This selective toxicity, together with the ability to complex and release siRNA, suggests that these new polylysine dendrons might offer a scaffold in the development of future nanoparticles designed to restrict the proliferation of glioblastoma cells.

SUBMITTER: Janiszewska J 

PROVIDER: S-EPMC5104433 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Second Generation Amphiphilic Poly-Lysine Dendrons Inhibit Glioblastoma Cell Proliferation without Toxicity for Neurons or Astrocytes.

Janiszewska Jolanta J   Posadas Inmaculada I   Játiva Pablo P   Bugaj-Zarebska Marta M   Urbanczyk-Lipkowska Zofia Z   Ceña Valentín V  

PloS one 20161110 11


Glioblastomas are the most common malignant primary brain tumours in adults and one of the most aggressive and difficult-to-treat cancers. No effective treatment exits actually for this tumour and new therapeutic approaches are needed for this disease. One possible innovative approach involves the nanoparticle-mediated specific delivery of drugs and/or genetic material to glioblastoma cells where they can provide therapeutic benefits. In the present work, we have synthesised and characterised se  ...[more]

Similar Datasets

| S-EPMC4004214 | biostudies-literature
| S-EPMC8877797 | biostudies-literature
| S-EPMC8482192 | biostudies-literature
| S-EPMC4829237 | biostudies-literature
| S-EPMC7560395 | biostudies-literature
| S-EPMC9414926 | biostudies-literature
| S-EPMC4208291 | biostudies-literature
| S-EPMC6836210 | biostudies-literature
| S-EPMC7057326 | biostudies-literature
| S-EPMC10853758 | biostudies-literature